Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: The Role of Budesonide Intrapolyp Injection in CRSwNP [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating budesonide intrapolyp injection for chronic rhinosinusitis with nasal polyps (CRSwNP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide intrapolyp injection (budesonide)

Snippet

Sponsor: Kafrelsheikh University | Conditions: CRS, Polyp, Nasal | Phase 4 | Status: UNKNOWN